The global health community is closely monitoring mpox (formerly known as monkeypox) as cases continue to emerge, including a recent confirmed case in Brasília, Brazil. While health officials emphasize that the current situation does not constitute an epidemic, vigilance and public awareness remain crucial. As of February 26, 2026, Brazil has reported 88 confirmed cases of mpox this year, with the majority concentrated in São Paulo, accounting for 62 cases. Other affected states include Rio de Janeiro (15), Rondônia (4), Minas Gerais (3), Rio Grande do Sul (2), Paraná (1) and the Federal District (1). This follows a more significant outbreak in 2025, which saw 1,079 cases and two fatalities nationwide.
Experts, like infectious disease specialist Henrique Lacerda of Hospital Brasília, part of the Rede Américas, stress that mpox currently exhibits relatively low lethality and controllable transmission rates. This allows for effective identification of cases, isolation of infected individuals, and monitoring of their contacts. The virus, first identified in the 1970s, initially spread from animals to humans but has since adapted to facilitate human-to-human transmission. Transmission occurs through direct contact with skin lesions, bodily fluids, blood, or mucous membranes of an infected person, and is not limited to specific demographic groups.
Understanding Mpox Transmission and Symptoms
Mpox is caused by a virus belonging to the Orthopoxvirus genus, the same family as the variola virus, which causes smallpox. The World Health Organization (WHO) details that transmission can occur through close physical contact, including sexual contact, contact with contaminated objects (such as clothing or bedding), and, in some situations, through respiratory droplets during prolonged face-to-face interaction. The WHO outlines these transmission pathways, emphasizing the importance of hygiene and safe practices.
The initial symptoms of mpox often include fever, headache, muscle aches, and swollen lymph nodes. These are typically followed by the development of a rash, characterized by blisters or sores that can appear on the face, palms of the hands, soles of the feet, genitals, or anal region. These lesions can resemble those of other diseases, such as chickenpox, herpes, or syphilis, making accurate diagnosis essential. Importantly, some individuals may experience mild symptoms or even be asymptomatic, contributing to the complexity of tracking and controlling the spread of the virus.
Vaccination and Treatment Options
While there is no specific treatment currently available for mpox, supportive care is provided to manage symptoms and prevent complications. Individuals infected with mpox are advised to isolate themselves until all lesions have completely healed to minimize the risk of transmission. The Brazilian Ministry of Health makes vaccination against mpox available through the Unified Health System (SUS) for prioritized groups, including healthcare workers and individuals with compromised immune systems. The Agência Brasil reports on the availability of vaccination, highlighting the government’s efforts to protect vulnerable populations.
The Jynneos vaccine, a modified vaccinia Ankara (MVA) vaccine, has been authorized for use against mpox in several countries, including the United States and within the European Union. It is administered in a two-dose series and has demonstrated efficacy in preventing the disease. However, vaccine supply and access remain challenges in some regions.
The Importance of Vigilance and Concurrent Health Concerns
Beyond mpox, health officials are also emphasizing the importance of maintaining high vaccination rates against other preventable diseases, such as measles. Dr. Lacerda highlighted the potential for measles outbreaks, noting that Brazil recorded 38 cases in 2025. Measles is a highly contagious viral infection that can lead to serious complications, particularly in young children, the elderly, and individuals with weakened immune systems. Maintaining an up-to-date vaccination schedule is considered the most effective way to protect both individuals and the community.
The current situation underscores the ongoing require for robust public health surveillance systems, rapid diagnostic capabilities, and effective communication strategies to address emerging infectious disease threats. Continued research is also crucial to develop novel and improved vaccines and treatments for mpox and other viral infections.
Mpox vs. Smallpox: Understanding the Differences
Although mpox and smallpox share similarities due to their belonging to the Orthopoxvirus genus, there are key distinctions. Mpox symptoms are generally milder than those of smallpox, and the virus is less contagious. Historically, smallpox caused significantly higher mortality rates and widespread outbreaks before its eradication through global vaccination efforts in 1980. However, because prior smallpox vaccination can offer some cross-protection against mpox, individuals vaccinated against smallpox in the past may experience milder symptoms if infected.
What to Do If You Suspect Mpox
If you develop symptoms consistent with mpox, such as fever, headache, muscle aches, and a characteristic rash, it is essential to seek medical attention immediately. Inform your healthcare provider about any recent travel history or potential exposure to individuals with suspected or confirmed mpox. Avoid close contact with others, and practice excellent hygiene, including frequent handwashing and avoiding sharing personal items.
Health authorities are continuously updating their guidance on mpox prevention and control. For the most current information, consult the websites of the World Health Organization (www.who.int/news-room/fact-sheets/detail/monkeypox) and the Brazilian Ministry of Health. Staying informed and taking appropriate precautions are vital steps in protecting yourself and your community from this evolving health threat.
The Ministry of Health is expected to release updated epidemiological data on mpox cases in Brazil on March 15, 2026. Continued monitoring of the situation and adherence to public health recommendations are essential to prevent further spread and protect vulnerable populations. We encourage readers to share this information and engage in open discussions about mpox prevention and preparedness.
Keep reading